Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ITFG2 | Human | (+)-schisandrin B | multiple interactions | ISO | Itfg2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ITFG2 mRNA] | CTD | PMID:31150632 | ITFG2 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Itfg2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ITFG2 mRNA | CTD | PMID:36331819 | ITFG2 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Itfg2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ITFG2 mRNA | CTD | PMID:22206623 | ITFG2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Itfg2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ITFG2 mRNA | CTD | PMID:21570461 | ITFG2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Itfg2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ITFG2 mRNA | CTD | PMID:33387578 | ITFG2 | Human | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of ITFG2 gene | CTD | PMID:31601247 | ITFG2 | Human | aflatoxin B1 | increases expression | ISO | Itfg2 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of ITFG2 mRNA | CTD | PMID:19770486 | ITFG2 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of ITFG2 gene | CTD | PMID:27153756 | ITFG2 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of ITFG2 mRNA | CTD | PMID:33167477 | ITFG2 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of ITFG2 mRNA | CTD | PMID:24449571 | ITFG2 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of ITFG2 mRNA | CTD | PMID:33212167 | ITFG2 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of ITFG2 gene | CTD | PMID:25304211 | ITFG2 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of ITFG2 gene | CTD | PMID:25304211 | ITFG2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ITFG2 promoter | CTD | PMID:27901495 | ITFG2 | Human | bisphenol A | decreases expression | ISO | Itfg2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ITFG2 mRNA | CTD | PMID:25181051 | ITFG2 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ITFG2 gene] | CTD | PMID:28238834 | ITFG2 | Human | chloroacetaldehyde | decreases expression | EXP | | 6480464 | chloroacetaldehyde results in decreased expression of ITFG2 mRNA | CTD | PMID:25596134 | ITFG2 | Human | cidofovir anhydrous | affects expression | EXP | | 6480464 | Cidofovir affects the expression of ITFG2 mRNA | CTD | PMID:25596134 | ITFG2 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ITFG2 mRNA | CTD | PMID:25596134 | ITFG2 | Human | cyclosporin A | decreases expression | ISO | Itfg2 (Rattus norvegicus) | 6480464 | Cyclosporine results in decreased expression of ITFG2 mRNA | CTD | PMID:21865292 | ITFG2 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ITFG2 mRNA | CTD | PMID:25562108 and PMID:25596134 | ITFG2 | Human | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of ITFG2 mRNA | CTD | PMID:25596134 | ITFG2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ITFG2 mRNA | CTD | PMID:27188386 | ITFG2 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ITFG2 mRNA | CTD | PMID:29803840 | ITFG2 | Human | endosulfan | increases expression | ISO | Itfg2 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of ITFG2 mRNA | CTD | PMID:29391264 | ITFG2 | Human | ethanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ITFG2 mRNA | CTD | PMID:29432896 | ITFG2 | Human | ethanol | affects expression | ISO | Itfg2 (Mus musculus) | 6480464 | Ethanol affects the expression of ITFG2 mRNA | CTD | PMID:30319688 | ITFG2 | Human | fenofibrate | increases expression | EXP | | 6480464 | Fenofibrate results in increased expression of ITFG2 mRNA | CTD | PMID:25596134 | ITFG2 | Human | folic acid | multiple interactions | ISO | Itfg2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ITFG2 mRNA | CTD | PMID:22206623 | ITFG2 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of ITFG2 gene | CTD | PMID:31601247 | ITFG2 | Human | gentamycin | increases expression | ISO | Itfg2 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of ITFG2 mRNA | CTD | PMID:33387578 | ITFG2 | Human | ifosfamide | decreases expression | EXP | | 6480464 | Ifosfamide results in decreased expression of ITFG2 mRNA | CTD | PMID:25596134 | ITFG2 | Human | monosodium L-glutamate | decreases expression | ISO | Itfg2 (Mus musculus) | 6480464 | Sodium Glutamate results in decreased expression of ITFG2 mRNA | CTD | PMID:22078008 | ITFG2 | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ITFG2 mRNA | CTD | PMID:35430440 | ITFG2 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Itfg2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ITFG2 mRNA | CTD | PMID:36331819 | ITFG2 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ITFG2 mRNA | CTD | PMID:23557933 | ITFG2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ITFG2 mRNA | CTD | PMID:27188386 | ITFG2 | Human | tetrachloromethane | multiple interactions | ISO | Itfg2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ITFG2 mRNA] | CTD | PMID:31150632 | ITFG2 | Human | tetrachloromethane | increases expression | ISO | Itfg2 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of ITFG2 mRNA | CTD | PMID:31150632 | ITFG2 | Human | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of ITFG2 mRNA | CTD | PMID:28542535 | ITFG2 | Human | valproic acid | decreases expression | ISO | Itfg2 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of ITFG2 mRNA | CTD | PMID:21427059 | ITFG2 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ITFG2 mRNA | CTD | PMID:25979313 | ITFG2 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ITFG2 mRNA | CTD | PMID:26272509 and PMID:29154799 | ITFG2 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ITFG2 mRNA | CTD | PMID:27188386 | ITFG2 | Human | zoledronic acid | decreases expression | EXP | | 6480464 | zoledronic acid results in decreased expression of ITFG2 mRNA | CTD | PMID:25596134 | |